Brief: Pharming Group Issues EUR 100 Million Convertible Bonds Due 2029

Pharming

18/04/2024 14:18

April 18 (Reuters) - Pharming Group NV  PHAR.AS :
    * PHARMING GROUP ANNOUNCES PLACEMENT OF EUR 100 MILLION
CONVERTIBLE BONDS DUE 2029
    * NEW BONDS WILL HAVE A PRINCIPAL AMOUNT OF EUR 100,000 EACH
    * NEW BONDS WILL BE ISSUED AT PAR AND WILL CARRY A COUPON OF
4.50%
PER ANNUM
    * INITIAL CONVERSION PRICE HAS BEEN SET AT EUR 1.2271,
REPRESENTING A PREMIUM OF 37.5%
    * INVITATION IS EXPECTED TO CLOSE AT 5.30PM CET ON 19TH
APRIL 2024
    * COMPANY WILL USE NET PROCEEDS OF NEW BONDS FOR REPURCHASE
OF
OUTSTANDING EUR 125 MILLION 3.00% SENIOR UNSECURED CONVERTIBLE
BONDS DUE 2025

Source text for WorkSpace:  urn:newsml:reuters.com:*:nGNE5qh0LV
Further company coverage:  PHAR.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))